Mammary Gland: Focus on metabolic health

This review considers current ideas about the stages of development of pathological dysplastic processes in the mammary glands, data from reviews and meta-analyzes to study the causes of their development, factors of progression, the risk of their further influence on the formation of breast cancer. The use of a selective estrogen receptor modulator drug is considered as an etiopathogenetic correction of the patient’s existing disease, as its main pathological cause, and a risk factor for further proliferative and mitotic activity — long-term hyperestrogenism, the results of clinical studies in real clinical practice were evaluated.